Atrial fibrillation (AF) is one of the most common tachyarrhythmias observed in the clinic and
is characterized by structural and electrical remodelling. Atrial fibrosis, an emblem of atrial …

Abstract Purpose of Review Stroke prevention is the cornerstone of atrial fibrillation (AF)
management and the anticoagulation decision is currently based on CHA 2 DS 2-VASc risk …

Background Atrial fibrillation (AF), which affects 1% to 4% of the general population, is an
important risk factor for stroke. New technologies for AF screening are now available, but …

Background: Atrial fibrillation (AF) is a well-known risk factor for stroke. Predicting the risk is
important to prevent the first and secondary attacks of cerebrovascular diseases by …

Subclinical atrial fibrillation (SCAF) describes asymptomatic episodes of atrial fibrillation
(AF) that are detected by cardiac implantable electronic devices (CIED). The increased …

Abstract Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan city, China in December 2019 …

Background Atrial fibrillation occurs when rapid and disorganized electrical signals cause
the atria in the heart to beat irregularly and is associated with an increased risk for stroke …

Background Atrial fibrillation (AF) has been associated with an increased risk of silent brain
infarcts (SBI) and cognitive impairment, even in patients with low embolic risk. We aimed to …

Left atrial appendage (LAA) thrombus detachment resulting in intracranial embolism is a
major complication of atrial fibrillation (AF). Endocardial endothelial cell (EEC) injury leads …

Aims Data on the optimal use of antithrombotic drugs and associated clinical outcomes in
patients with atrial fibrillation (AF) and acute ischaemic stroke (IS) are limited. We …